PATENT CLAIM ANALYSIS

Application Number: 16016409
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "001100"]

Abstract:
Conjugates of carriers and hydrogels for controlling the biological half-life of somatostatin and its analogs are disclosed.

Claim (Index 7):
The method of  claim 6  wherein the condition is associated with growth hormone producing tumors (acromegaly and gigantism), pituitary tumors that secrete thyroid stimulating hormone (thyrotropinoma), diarrhea, flushing episodes associated with carcinoid syndrome, or diarrhea in patients with vasoactive intestinal peptide-secreting tumors (VIPomas).

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15030353', '13696299', '14343819', '13696300', '15652947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8111907536598225
- 35 USC 102 Novelty (BERT): 0.5546985011540689
- Combined Prediction Score: 0.7855415284092471
- Mean Citation Score: 331.880824
- Max Citation Score: 462.73483
- Similarity Product: 267.6528386084246

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test